Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2800 participants
OBSERVATIONAL
2024-02-01
2043-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure group
Group with environmental, nutritional or lifestyle exposures
No Interventions
No intervention This is an observational study without any intervention
Non-exposed group
Group without any environmental, nutritional and lifestyle exposures
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Interventions
No intervention This is an observational study without any intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Pregnant women, 6-13\^+6 gestational weeks
2. Resided in Weifang in the past half years and have no plan to move out after delivery
3. Pregnant women who plan to have antenatal care and delivery in Weifang maternal\&Child Hospital.
4. Pregnant women who is willing to participate in this study with informed consent
* Pregnant woman's husband
1. His wife was eligible for enrollment
2. He is the biological father of the child (his wife's current pregnancy)
3. Pregnant women's husband who is willing to participate in this study with informed consent
5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Natural Science Foundation of China
OTHER_GOV
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hai-Jun Wang
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haijun Wang, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Peking University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Haijun Wang, Ph.D
Role: primary
Jue Liu, Ph.D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKUBC-WF
Identifier Type: -
Identifier Source: org_study_id